The effects of treatment on itch in atopic dermatitis

Dermatologic Therapy

Volumn 26, Issue 2, 2013, Pages 110-119

  Yarbrough, Kevin B ^a   Neuhaus, Kristin J ^a   Simpson, Eric L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

atopic dermatitis; itch; pruritus

Indexed keywords

ANTIINFLAMMATORY AGENT;

ARTICLE; ATOPIC DERMATITIS; DISEASE ASSOCIATION; PRURITUS; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ANTI-INFLAMMATORY AGENTS; DERMATITIS, ATOPIC; DRUG DESIGN; HUMANS; INFLAMMATION; PRURITUS; QUALITY OF LIFE;

EID: 84875823936     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/dth.12032     Document Type: Article

References (82)

1. Hanifin JM, Rajka G,. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980: 92: 44-47.
2. Williams HC, Burney PG, Pembroke AC, Hay RJ,. The UK Working Party's diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol 1994: 131 (3): 406-416.
3. Hafenreffer S,. De pruritu. Nosodochium, in Quo Cutis, Eique Adhaerentium Partium, Affectus Omnes, Singulari Methodo, et Cognoscendi Et Curandi Fidelissime Traduntur. Ulm. Typis & Expensis Balthasar. Kuhnen, 1660: 98-102.
4. Rukwied R, Lischetzki G, McGlone F, Heyer G, Schmelz M,. Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study. Br J Dermatol 2000: 142 (6): 1114-1120.
5. Yosipovitch G, Papoiu AD,. What causes itch in atopic dermatitis? Curr Allergy Asthma Rep 2008: 8 (4): 306-311.
6. Buddenkotte J, Steinhoff M,. Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy 2010: 65 (7): 805-821.
7. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994: 19 (3): 210-216.
8. Rees JL,. Measurement of itch using actigraphy in pediatric and adult populations. J Am Acad Dermatol 2004: 51: 893-898.
9. Murray CS, Rees JL,. Are subjective accounts of itch to be relied on? The lack of relation between visual analogue itch scores and actigraphic measures of scratch. Acta Derm Venereol 2011: 91 (1): 18-23.
10. Bringhurst C, Waterston K, Schofield O, Benjamin K, Rees JL,. Measurement of itch using actigraphy in pediatric and adult populations. J Am Acad Dermatol 2004: 51 (6): 893-898.
11. Langan S, Williams H,. What causes worsening of eczema? A systematic review. Br J Dermatol 2006: 155 (3): 504-514.
12. Yosipovitch G, Goon AT, Wee J, Chan YH, Zucker I, Goh CL,. Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus. Int J Dermatol 2002: 41 (4): 212-216.
13. Hanifin JM,. Pharmacophysiology of atopic dermatitis. Clin Rev Allergy 1986: 4: 43-65.
14. Beltrani VS,. The clinical spectrum of atopic dermatitis. J Allergy Clin Immunol 1999: 104 (3 Pt 2): S87-S98.
15. Hanifin JM,. Basic and clinical aspects of atopic dermatitis. Ann Allergy 1984: 52 (6): 386-393.
16. Ständer S, Steinhoff M,. Pathophysiology of pruritus in atopic dermatitis: an overview. Exp Dermatol 2002: 11 (1): 12-24.
17. Bendsöe N, Björnberg A, Asnes H,. Itching from wool fibres in atopic dermatitis. Contact Dermatitis 1987: 17 (1): 21-22.
18. Wahlgren CF,. Itch and atopic dermatitis: clinical and experimental studies. Acta Derm Venereol Suppl (Stockh) 1991: 165: 1-53.
19. Fisher AA,. Nonallergic "itch" and "prickly" sensation to wool fibers in atopic and nonatopic persons. Cutis 1996: 58 (5): 323-324.
20. Saeki H, Furue M, Furukawa F, et al. Guidelines for management of atopic dermatitis. J Dermatol 2009: 36 (10): 563-577.
21. Ellis C, Luger T, Abeck D, et al. International Consensus Conference on Atopic Dermatitis II (ICAAD II): clinical update and current treatment strategies. Br J Dermatol 2003: 148 (Suppl 63): 3-10.
22. Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB,. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol 2003: 49 (6): 1088-1095.
23. Tadicherla S, Ross K, Shenefelt P, Fenske N,. Topical corticosteroids in dermatology. J Drugs Dermatol 2009: 8 (12): 1093-1105.
24. Hanifin JM,. Atopic dermatitis. Broadening the perspective. J Am Acad Dermatol 2004: 51 (1): S23-S24.
25. Hoare C, Li Wan Po A, Williams H,. Systematic review of treatments for atopic eczema. Health Technol Assess 2000: 4 (37): 1-191.
26. Wahlgren CF, Hägermark O, Bergström R, Hedin B,. Evaluation of a new method of assessing pruritus and antipruritic drugs. Skin Pharmacol 1988: 1 (1): 3-13.
27. Maloney JM, Morman MR, Stewart DM, Tharp MD, Brown JJ, Rajagopalan R,. Clobetasol propionate emollient 0.05% in the treatment of atopic dermatitis. Int J Dermatol 1998: 37 (20): 142-144.
28. Roth HL, Brown EP,. Hydrocortisone valerate. Double-blind comparison with two other topical steroids. Cutis 1978: 21 (50): 695-698.
29. Kaplan RJ, Daman L, Rosenberg EW, Feigenbaum S,. Topical use of caffeine with hydrocortisone in the treatment of atopic dermatitis. Arch Dermatol 1978: 114 (1): 60-62.
30. Sefton J, Kyriakopoulos AA,. Comparative efficacy of hydrocortisone valerate 0.2 percent ointment in the treatment of atopic dermatitis. Cutis 1983: 32 (1): 89-91, 94.
31. Lassus A,. Clinical comparison of alclometasone dipropionate cream 0.05% with hydrocortisone butyrate cream 0.1% in the treatment of atopic dermatitis in children. J Int Med Res 1983: 11 (5): 315-319.
32. Lassus A,. Alclometasone dipropionate cream 0.05% versus clobetasone butyrate cream 0.05%. A controlled clinical comparison in the treatment of atopic dermatitis in children. Int J Dermatol 1984: 23 (8): 565-566.
33. Sher LG, Chang J, Patel IB, Balkrishnan R,. Relieving the pruritus of atopic dermatitis: a meta-analysis. Acta Derm Venereol 2012: 92 (5): 455-461.
34. Peserico A, Stadtler G, Sebastian M, Fernandez RS, Vick K, Bieber T,. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol 2008: 158 (4): 801-807.
35. Luger T, Van Leent EJ, Graeber M, et al. SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol 2001: 144 (4): 788-794.
36. Reitamo S, Harper J, Bos JD, et al. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized, double-blind controlled trial. Br J Dermatol 2004: 150 (3): 554-562.
37. Richelson E,. Antimuscarinic and other receptor-blocking properties of antidepressants. Mayo Clin Proc 1983: 58 (1): 40-46.
38. Drake LA, Fallon JD, Sober A,. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group. J Am Acad Dermatol 1994: 31 (4): 613-616.
39. Drake LA, Millikan LE,. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group. Arch Dermatol 1995: 1331 (12): 1403-1408.
40. Shelley WB, Shelley ED, Talanin NY,. Self-potentiating allergic contact dermatitis caused by doxepin hydrochloride cream. J Am Acad Dermatol 1996: 34 (1): 143-144.
41. Bromm B, Scharein E, Darsow U, Ring J,. Effects of menthol and cold on histamine-induced itch and skin reactions in man. Neurosci Lett 1995: 187 (3): 157-160.
42. Peier AM, Moqrich A, Hergarden AC, et al. A TRP channel that senses cold stimuli and menthol. Cell 2002: 108 (5): 705-715.
43. Patel T, Ishiuji Y, Yosipovitch G,. Menthol: a refreshing look at this ancient compound. J Am Acad Dermatol 2007: 57 (5): 873-878.
44. Dvorak M, Watkinson A, McGlone F, Rukwied R,. Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin. Inflamm Res 2003: 52 (6): 238-245.
45. Eberlein B, Eicke C, Reinhardt HW, Ring J,. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). J Eur Acad Dermatol Venereol 2008: 22 (1): 73-82.
46. Weisshaar E, Szepietowski JC, Darsow U, et al. European guideline on chronic pruritus. Acta Derm Venereol 2012: 92 (5): 563-581.
47. Hanifin JM,. The role of antihistamines in atopic dermatitis. J Allergy Clin Immunol 1990: 86 (4 Pt 2): 666-669.
48. Behrendt H, Ring J,. Histamine, antihistamines and atopic eczema. Clin Exp Allergy 1990: 20 (Suppl 4): 25-30.
49. Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J Am Acad Dermatol 2004: 50 (3): 391-404.
50. Yanai K, Rogala B, Chugh K, Paraskakis E, Pampura AN, Boev R,. Safety considerations in the management of allergic diseases: focus on antihistamines. Curr Med Res Opin 2012: 28 (4): 623-642.
51. Amor KT, Ryan C, Menter A,. The use of cyclosporine in dermatology: part 1. J Am Acad Dermatol 2010: 63 (6): 925-946.
52. Schmitt J, Schmitt N, Meurer M,. Cyclosporin in the treatment of patients with atopic eczema-a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2007: 21 (5): 606-619.
53. Harper JI, Ahmed I, Barclay G, et al. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol 2000: 142 (1): 52-58.
54. Pacor ML, Di Lorenzo G, Martinelli N, Mansueto P, Rini GB, Corrocher R,. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study. Clin Exp Allergy 2004: 34 (4): 639-645.
55. Czech W, Bräutigam M, Weidinger G, Schöpf E,. A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life. J Am Acad Dermatol 2000: 42 (4): 653-659.
56. Schmitt J, Schäkel K, Schmitt N, Meurer M,. Systemic treatment of severe atopic eczema: a systematic review. Acta Derm Venereol 2007: 87 (2): 100-111.
57. Schram ME, Roekevisch E, Leeflang MM, Bos JD, Schmitt J, Spuls PI,. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol 2011: 128 (2): 353-359.
58. Meggitt SJ, Gray JC, Reynolds NJ,. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomized controlled trial. Lancet 2006: 367 (9513): 839-846.
59. Berth-Jones J, Takwale A, Tan E, et al. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br J Dermatol 2002: 147 (2): 324-330.
60. Denby KS, Beck LA,. Update on systemic therapies for atopic dermatitis. Curr Opin Allergy Clin Immunol 2012: 12 (4): 421-426.
61. Haeck IM, Knol MJ, Ten Berge O, van, Velsen SG, de, Bruin-Weller MS, Bruijnzeel-Koomen CA,. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol 2011: 64 (6): 1074-1084.
62. Schmitt J, Schäkel K, Fölster-Holst R, et al. Prednisolone versus cyclosporin for severe adult eczema. An investigator-initiated double-blind placebo controlled multicentre trial. Br J Dermatol 2010: 162 (3): 661-668.
63. Chang TT, Stevens SR,. Atopic dermatitis: the role of recombinant interferon-gamma therapy. Am J Clin Dermatol 2002: 3 (3): 175-183.
64. Jang IG, Yang JK, Lee HJ, et al. Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma. J Am Acad Dermatol 2000: 42 (6): 1033-1040.
65. Hanifin JM, Schneider LC, Leung DYM, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993: 28 (2 Pt 1): 189-197.
66. Brehler R, Hildebrand A, Luger TA,. Recent developments in the treatment of atopic eczema. J Am Acad Dermatol 1997: 36 (6 Pt 1): 983-994.
67. Morison WL, Parrish J, Fitzpatrick TB,. Oral psoralen photochemotherapy of atopic eczema. Br J Dermatol 1978: 98 (1): 25-30.
68. Meduri NB, Vandergriff T, Rasmussen H, Jacobe H,. Phototherapy in the management of atopic dermatitis: a systematic review. Photodermatol Photoimmunol Photomed 2007: 23 (4): 106-112.
69. Reynolds NJ, Franklin V, Gray JC, Diffey BL, Farr PM,. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomized controlled trial. Lancet 2001: 357 (9273): 2012-2016.
70. Der-Petrossian M, Seeber A, Hönigsmann H, Tanew A,. Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol 2000: 142 (1): 39-43.
71. von Kobyletski G, Pieck C, Hoffmann K, Freitag M, Altmeyer P,. Medium-dose UVA1 cold-light phototherapy in the treatment of severe atopic dermatitis. J Am Acad Dermatol 1999: 41 (6): 931-937.
72. Nilsson HJ, Levinsson A, Schouenborg J,. Cutaneous field stimulation (CFS): a new powerful method to combat itch. Pain 1997: 71 (1): 49-55.
73. Pfab F, Hammes M, Bäcker M, et al. Preventive effect of acupuncture on histamine-induced itch: a blinded, randomized, placebo-controlled, crossover trial. J Allergy Clin Immunol 2005: 116 (6): 1386-1388.
74. Belgrade MJ, Solomon LM, Lichter EA,. Effect of acupuncture on experimentally induced itch. Acta Derm Venereol 1984: 64 (20): 129-133.
75. Lundeberg T, Bondesson L, Thomas M,. Effect of acupuncture on experimentally induced itch. Br J Dermatol 1987: 117 (6): 771-777.
76. Pfab F, Huss-Marp J, Gatti A, et al. Influence of acupuncture on type I hypersensitivity itch and the wheal and flare response in adults with atopic eczema-a blinded, randomized, placebo-controlled, crossover trial. Allergy 2010: 65 (7): 903-910.
77. Pfab F, Kirchner MT, Huss-Marp J, et al. Acupuncture compared with oral antihistamine for type I hypersensitivity itch and skin response in adults with atopic dermatitis: a patient- and examiner-blinded, randomized, placebo-controlled, crossover trial. Allergy 2012: 67 (4): 566-573.
78. Lee KC, Keyes A, Hensley JR, Kwasny MJ, West DP, Lio PA,. Effectiveness of acupressure on pruritus and lichenification associated with atopic dermatitis: a pilot trial. Acupunct Med 2012: 30 (1): 8-11.
79. Schachner L, Field T, Hernandez-Reif M, Duarte AM, Kraasnegor J,. Atopic dermatitis symptoms decreased in children following massage therapy. Pediatr Dermatol 1998: 15 (5): 390-395.
80. Ständer S, Weisshaar E,. Medical treatment of pruritus. Expert Opin Emerg Drugs 2012: 17 (3): 335-345.
81. Metze D, Reimann S, Beissert S, Luger T,. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological disease. J Am Acad Dermatol 1999: 41 (4): 533-539.
82. Simpson EL,. Atopic dermatitis: a review of topical treatment options. Curr Med Res Opin 2010: 26 (3): 633-640.